ICRNX | MGLMX | ICRNX / MGLMX | |
Total Expense Ratio | 1.50 | 0.94 | 160% |
Annual Report Gross Expense Ratio | 1.66 | 0.95 | 175% |
Fund Existence | 19 years | 10 years | - |
Gain YTD | 3.711 | 2.491 | 149% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 143M | 2.28B | 6% |
Annual Yield % from dividends | 2.56 | 2.53 | 101% |
Returns for 1 year | 6.57 | 3.36 | 196% |
Returns for 3 years | -4.32 | -9.31 | 46% |
Returns for 5 years | 5.76 | 11.23 | 51% |
Returns for 10 years | 14.56 | 23.17 | 63% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PSSIX | 23.82 | N/A | N/A |
Principal SmallCap S&P 600 Index Inst | |||
JNGLX | 65.49 | N/A | N/A |
Janus Henderson Global Life Sciences D | |||
TEOOX | 9.19 | N/A | N/A |
Transamerica Emerging Markets Eq R6 | |||
SIEYX | 13.68 | N/A | N/A |
Saratoga International Equity A | |||
VLIIX | 13.28 | -0.07 | -0.52% |
Value Line Capital Appreciation Instl |